Symbols

MDCX

Medicus Pharma·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About MDCX

Medicus Pharma Ltd.

A biotechnology and life science company focused on accelerating clinical development plans for new and disruptive therapeutic assets

Industry

Biological Technology

Established Date

04/30/2008

Listing Date

11/14/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.medicuspharma.com

Security Type

Common stock

Office address

300 Conshohocken State Rd. Suite 200 W. Conshohocken PA 19428

Business

Introduction

Medicus Pharma Ltd., was incorporated on April 30, 2008 under the laws of the province of Ontario, Canada. The company is a clinical-stage multi-strategy biotechnology/life sciences company focused on investing in and accelerating clinical development programs for new and potentially disruptive therapeutic assets. The company examines opportunities in all therapeutic areas where there is an unmet need to improve patient safety and efficacy. The company is opportunistically exploring to expand its drug development pipeline through qualified and value-added acquisitions and collaborations.

Company Financials

EPS

MDCX has released its 2025 Q2 earnings. EPS was reported at -0.43, versus the expected -0.25, missing expectations. The chart below visualizes how MDCX has performed over recent quarters, highlighting trends in earnings surprises.